Nutra Pharma Short Interest Ratio and Short Volume

Short interest is the volume of Nutra Pharma shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 100 shares of NPHC short. Learn More on Nutra Pharma's current short interest.

Nutra Pharma saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 100 shares, a decrease of 98.9% from the previous total of 9,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Nutra Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "medicinals & botanicals" compare to Nutra Pharma: Grove, Inc. (2.24%), FitLife Brands, Inc. (0.00%), Mannatech, Incorporated (0.10%), Glucose Health, Inc. (0.00%), Happiness Biotech Group Limited (3.93%), General Cannabis Corp (0.00%), Tauriga Sciences, Inc. (0.00%), Exactus Inc (0.00%), GLG Life Tech Co. (0.00%), and Rock Creek Pharmaceuticals, Inc. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

Short selling NPHC is an investing strategy that aims to generate trading profit from Nutra Pharma as its price is falling. To short Nutra Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Nutra Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nutra Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NPHC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NPHC, twice per month. The most recent reporting period available is August, 31 2021.